Register
Login:
Share:
Email Facebook Twitter

RNS VIDEO: Reabold Resources #RBD raise £6 million and take stake in Danube Petroleum Watch here

EXCLUSIVE: HemoGenyx are creating blood cancer treatments with US$9 billion market potential


Regulatory News


Notice of Dividend

Thu, 7th Dec 2017 15:11


RNS Number : 7337Y
Assura PLC
07 December 2017

7 December 2017

Assura plc

Notice of Dividend

Assura plc ("Assura" or "the Company"), the UK's leading primary care property investor and developer, today announces that the next quarterly interim dividend of 0.655 pence per share will be paid on 17 January 2018 to shareholders on the register on 15 December 2017 (the "Record Date"). The Ex-dividend Date will be 14 December 2017.

This interim dividend will be a normal dividend (Non-PID). Please refer to Company's website HERE for more information.

Shareholders may choose for the dividend to be paid either as cash or to be settled in New Shares via the Scrip Dividend Alternative. The Scrip Dividend Alternative price is to be calculated using the average of the middle market quotations for an Ordinary Share, as derived from the Daily Official List of the London Stock Exchange, for the five consecutive business days commencing on the Ex-dividend Date and will be announced by the Company and detailed on the Company's website on 21 December 2017.

Any shareholders wishing to take up the Scrip Dividend Alternative, who have not already done so, will have until 4.30pm on 3 January 2018 either to return their completed mandate form to the Company registrars, Link Asset Services at The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU (in the case of shareholdings in certificated form) or to take the necessary action via the CREST system (in the case of shareholdings in uncertificated form).

The Circular concerning this Scrip Dividend Alternative is available on the Company's website,www.assuraplc.com and is also available for inspection at the National Storage Mechanismhttp://www.morningstar.co.uk/uk/NSM.

- Ends -

For more information, please contact:

Assura plc

Tel: 01925 420660

Orla Ball


Edelman

John Kiely

Tel: 0203 047 2546

Mav Wynn


Rob Yates


Notes to Editors

Assura plc, a constituent of the FTSE 250 and the EPRA* indices, is a UK REIT and long-term investor in and developer of primary care property. The company, headquartered in Warrington, works with GPs, health professionals and the NHS to create innovative property solutions in order to facilitate delivery of high quality patient care in the community. At 30 September 2017, Assura's property portfolio was valued at 1.56 billion.

Further information is available at www.assuraplc.com

*EPRA is a registered trademark of the European Public Real Estate Association


This information is provided by RNS
The company news service from the London Stock Exchange
END
DIVUGGRUPUPMGAM


Related Shares:
Assura (AGR)



Back to Regulatory News


Share Price, Share Chat, Stock Market news at lse.co.uk
FREE Member Services
- Setup a personalised Watchlist and Virtual Portfolio.
- Gain access to LIVE real-time Regulatory News (RNS).
- View more Trades, Directors' Deals, and Broker Ratings.
Share Price, Share Chat, Stock Market news at lse.co.uk




Datafeed and UK data supplied by NBTrader and Digital Look. While London South East do their best to maintain the high quality of the information displayed on this site,
we cannot be held responsible for any loss due to incorrect information found here. All information is provided free of charge, 'as-is', and you use it at your own risk.
The contents of all 'Chat' messages should not be construed as advice and represent the opinions of the authors, not those of London South East Limited, or its affiliates.
London South East does not authorise or approve this content, and reserves the right to remove items at its discretion.